Different Stages of a Mass Tort Case Explained

TL;DR

• A mass tort case moves through seven stages: investigation, plaintiff acquisition, filing, MDL consolidation, discovery, bellwether trials, and settlement. Cases can settle at any point. The full process typically takes three to ten or more years depending on defendant, injury type, and plaintiff volume.
• This guide explains what a mass tort case is, how it differs from a class action, what happens at each stage, how long the process takes, and what types of cases most commonly become mass torts.

Mass tort litigation involves some of the most complex cases in the U.S. civil justice system. Hundreds or thousands of individual plaintiffs may share an injury source, yet each pursues their own separate claim. Managing that scale without losing individual merits is the core challenge.

According to the JPML data, MDL cases have represented more than 70% of the total federal civil caseload in recent years, reflecting just how dominant mass tort litigation has become in the federal court system.

Understanding the stages of a mass tort case helps attorneys, plaintiffs, and legal operations teams know what to expect at each phase, where the critical decisions get made, and why preparation early in the process shapes outcomes at the end.

What Is a Mass Tort Case?

A mass tort is a civil action where numerous plaintiffs each retain their own individual personal injury case with damages calculated separately based on the specific harm they suffered.

The common thread is the defendant’s conduct. Whether the mass tort claims arise from a dangerous drug, a defective product, or an environmental hazard, plaintiffs share a common injury source even when their individual circumstances differ.

What is a mass tort lawsuit structurally? Each plaintiff’s case remains individual even after MDL consolidation. Damages are not split equally but assessed based on each person’s specific injuries, medical history, and losses.

Mass Tort vs. Class Action: Key Differences

Mass tort litigation is routinely confused with class action lawsuits. Both involve many plaintiffs with similar claims against the same defendant, but the legal structure and outcomes differ significantly.

Mass tort plaintiffs can reject settlement offers independently. Class action plaintiffs are generally bound by what class representatives negotiate. Personal injury case stages follow a different structure from both models.

The Different Stages of a Mass Tort Case

Each stage of a mass tort builds on the previous one. Cases can settle or be dismissed at any point, but most large MDLs move through all seven stages before resolution.

Stage 1: Initial Investigation and Case Evaluation

Before any lawsuit is filed, attorneys conduct extensive preliminary research to determine whether a mass tort case has merit. This involves reviewing scientific studies, regulatory actions, adverse event reports, and internal corporate documents when available.

For pharmaceutical cases, attorneys examine FDA safety communications and clinical trial data. For environmental cases, they review EPA records and independent scientific studies. The goal is a credible causal link before investing in plaintiff acquisition.

This stage also involves identifying the potential plaintiff pool. If the injury is narrowly defined and the affected population is small, the case may not support mass tort litigation. If there are thousands of people with the same exposure and similar injuries, a mass tort becomes viable.

Stage 2: Finding Plaintiffs and Building the Case

Mass torts case acquisition is one of the most demanding phases. Attorneys identify, screen, and sign plaintiffs who meet eligibility criteria for injury and exposure. PI attorneys handling mass tort intake evaluate each potential claimant’s medical records, exposure history, and injury timeline to confirm they fit the established case profile.

What is mass tort intake? It is a structured screening process where potential plaintiffs are evaluated against defined eligibility criteria before being signed. Intake uses questionnaires, medical record reviews, and exposure verification. Signing unqualified plaintiffs weakens the case and creates firm liability.

Law firms working mass torts often collaborate, with lead firms coordinating plaintiff acquisition across referral networks. Uniform case documentation from the beginning is critical because inconsistencies in how plaintiff data is collected create problems during discovery and at bellwether trial selection.

Stage 3: Filing and Court Selection

Individual lawsuits are filed by each plaintiff’s attorney in the appropriate federal or state court. For federal mass torts, the Judicial Panel on Multidistrict Litigation (JPML) evaluates whether the cases should be transferred to a single federal court for coordinated pretrial proceedings.

Where a case is filed can influence how quickly it moves into MDL and which judge oversees the litigation. Experienced mass tort attorneys consider the venue strategically, factoring in the judge’s track record with complex litigation and the jurisdiction’s procedural timelines before selecting the filing court.

Stage 4: Consolidation Into Multidistrict Litigation (MDL)

What is mass tort litigation at the MDL stage: the JPML consolidates lawsuits sharing common facts into a single MDL, eliminating duplicative discovery and preventing inconsistent rulings across districts.

The presiding judge appoints MDL leadership. Plaintiffs typically have Lead Counsel and a Plaintiff Steering Committee coordinating strategy, discovery, and expert preparation. Defense has a Defense Liaison Counsel and Defense Steering Committee in equivalent roles.

MDL does not mean the cases merge into one lawsuit. Each plaintiff retains their individual claim. MDL only consolidates the pretrial process. After pretrial proceedings conclude, cases that have not settled are remanded to their original courts for trial.

Stage 5: Discovery

Discovery in a mass tort MDL is one of the most resource-intensive phases in civil litigation. Both sides gather evidence through document production, depositions, interrogatories, expert reports, and medical record review. In large MDLs, the document volume can reach millions of pages.

Corporate document discovery is particularly significant in mass torts. Internal communications, product testing records, and executive emails have been decisive in pharmaceutical and device cases. Plaintiffs use this evidence to establish what the defendant knew and concealed.

Expert witnesses are central to mass tort discovery. General causation experts address whether the product can cause the alleged harm. Specific causation experts address individual plaintiff injury. Qualifying experts under the Daubert standard is among the most contested issues in any MDL.

Stage 6: Bellwether Trials

Courts select a small number of representative cases, called bellwether cases, to try before juries. These trials reveal how jurors respond to the evidence, how credible experts appear in court, and the likely damages range across the plaintiff pool.

Bellwether outcomes do not bind remaining cases but carry enormous practical weight. Defense verdicts signal that claims may not hold up and create defendant leverage. Plaintiff verdicts pressure defendants to settle before more cases reach trial.

Bellwether cases are carefully selected by both sides and the presiding judge. The selection process itself is strategic. Plaintiffs typically want cases that are most sympathetic and representative of serious injuries. Defendants prefer cases where liability is less clear or the plaintiff’s individual circumstances are complicated.

Stage 7: Settlement or Final Resolution

Most mass tort cases resolve through global settlement. After bellwether trials establish claim value ranges, both sides negotiate a settlement fund. Individual plaintiffs then decide whether to participate or opt out and pursue their own trial.

Settlement administration involves establishing a qualified fund and a claims process. Compensation is tiered by injury severity and exposure. Attorneys’ fees are deducted from the gross settlement before individual distributions are made.

Cases that do not settle in the MDL are remanded to their original courts for individual trial. These post-MDL trials are rare but occur when plaintiffs reject the settlement offer or when their cases fall outside the settlement parameters.

How Long Does a Mass Tort Case Take?

Mass tort litigation takes significantly longer than standard personal injury cases. Where a typical PI case might resolve in one to three years, mass torts routinely take five to ten years or longer from the first filing through final settlement distribution.

Several factors determine the timeline:

• Plaintiff volume: cases with tens of thousands of plaintiffs require longer discovery and more complex settlement administration than cases with a few hundred claimants.
• Defendant resources: large pharmaceutical companies and device manufacturers have the legal resources to contest every stage aggressively, extending timelines through motion practice and discovery disputes.
• Scientific complexity: cases that require novel expert testimony on causation take longer because both sides need time to develop, challenge, and litigate the admissibility of that science.
• Bellwether outcomes: a string of defense verdicts may slow settlement momentum; a plaintiff verdict in a bellwether often accelerates it.
• Regulatory context: if a government agency has already concluded the product is dangerous, litigation moves faster. If the science is contested, it slows considerably.

The opioid MDL ran years before a multi-billion dollar settlement. The 3M combat earplug MDL settled in 2023 for approximately $6 billion after more than 240,000 claimants joined. Camp Lejeune water contamination litigation filed in 2022 is still progressing.

Common Types of Mass Tort Cases

Mass torts arise across a wide range of types of personal injury cases, though the most common categories share one trait: a single defendant whose conduct or product affected large numbers of people in a similar way.

• Pharmaceutical and drug litigation: drugs that cause serious side effects not disclosed to patients or regulators. Examples include Risperdal, Zofran, and Vioxx.
• Medical device litigation: defective implants, surgical mesh, IVC filters, and hip replacement systems that fail and cause injury. Transvaginal mesh litigation was among the largest MDLs by plaintiff volume.
• Environmental and toxic tort: exposure to contaminated water, air, or soil caused by corporate activity. Examples include Camp Lejeune, PFAS contamination, and coal ash spills.
• Product liability: consumer products that cause injury due to design defects, manufacturing defects, or inadequate warnings. Examples include Roundup (glyphosate), talcum powder, and 3M earplugs.
• Consumer protection: deceptive practices that affect large numbers of consumers in similar ways, though these often intersect with class action litigation rather than traditional mass tort.

The Role of Case Management Software in Mass Tort Litigation

Managing hundreds or thousands of individual plaintiff files simultaneously is operationally impossible without purpose-built software. Each claimant has their own intake record, medical history, exposure documentation, and case status that must be tracked, updated, and accessible to the legal team at any point in the litigation.

Purpose-built mass tort case management software tracks plaintiff files at scale, manages document intake, flags missing records, and monitors case status across every MDL stage. Firms managing both mass tort and individual PI cases benefit from unified legal case management software that handles both without separate systems.

Bellwether selection, in particular, requires strong data infrastructure. The presiding judge and leadership counsel need to identify representative cases across injury severity, exposure levels, geography, and demographics. Firms that have clean, consistent plaintiff data from intake through the discovery phase have a meaningful advantage in that process.

The personal injury case management checklist provides a useful baseline for understanding what documentation and workflow standards matter most across the full lifecycle of a PI matter, many of which carry directly into mass tort case management requirements.

Conclusion

A mass tort case moves through seven stages, each requiring coordinated effort across legal teams, medical experts, and case management systems. Investigation establishes viability. Plaintiff acquisition determines scale. Discovery builds evidence. Bellwether trials set settlement range. Settlement administration distributes the outcome.

Attorneys who understand the full arc from the start make better strategic decisions at every stage. The firms that perform best in mass torts have clean plaintiff data, strong expert relationships, and systems that scale with the litigation.

At Gain Servicing, law firms managing mass tort and personal injury caseloads get purpose-built case management tools for tracking plaintiffs, coordinating medical records, and managing case workflows from intake through settlement.

FAQs

1. What is a mass tort case and how does it work?

A mass tort is a civil action in which many plaintiffs bring individual claims against one or more defendants over the same alleged harmful conduct. Each plaintiff retains their own lawsuit and receives damages based on their individual injuries. Cases are typically consolidated into MDL for pretrial proceedings to improve efficiency.

2. What is the difference between a mass tort and a class action lawsuit?

In a class action, one lawsuit represents all plaintiffs and damages are shared across the group. In a mass tort, each plaintiff files their own separate lawsuit with individual damages. Mass tort plaintiffs have more control over their claims and can reject a settlement independently. Class action plaintiffs are generally bound by the class outcome.

3. What types of cases commonly become mass torts?

The most common categories are pharmaceutical drug litigation, medical device failures, environmental and toxic exposure cases, and product liability. Well-known examples include the opioid crisis litigation, 3M combat earplug cases, talcum powder ovarian cancer claims, Roundup herbicide cases, and Camp Lejeune water contamination claims.

4. What is MDL and how does it apply to mass torts?

Multidistrict litigation (MDL) is a federal process that consolidates cases from multiple districts into one federal court for coordinated pretrial proceedings. The goal is to eliminate duplicate discovery and avoid inconsistent rulings. Individual cases are not merged; they retain their separate identities throughout the MDL and are remanded for trial if they do not settle.

5. What are bellwether trials and why do they matter?

Bellwether trials are a small set of representative cases tried before juries during an MDL to gauge how jurors respond to the evidence and arguments. They do not bind the remaining cases, but their outcomes heavily influence settlement negotiations. Plaintiff verdicts pressure defendants to settle; defense verdicts may lead plaintiffs to accept lower offers or dismiss weaker claims.

6. How long does a mass tort case typically take?

Most mass torts take five to ten years or more from initial filing through final settlement distribution. Factors include plaintiff volume, defendant resources, scientific complexity, and bellwether outcomes. Pharmaceutical and device cases are typically the longest due to contested causation science and extensive corporate discovery requirements.

7. Can I join a mass tort case after it has already been filed?

Yes. Mass tort MDLs typically remain open to new plaintiffs throughout the litigation, provided the new claimant meets the established eligibility criteria for injury type, product exposure, and timing. Most MDLs have case management orders that set deadlines for new filings. Joining early generally provides more time for complete case development.

8. How do mass tort case management systems help law firms handle hundreds of plaintiffs?

Mass tort case management software tracks individual plaintiff files at scale, manages document intake, flags missing records, monitors case status across MDL stages, and supports bellwether case selection with clean, consistent data. Without purpose-built systems, managing thousands of individual claimants across multiple intake sources and document types is operationally unmanageable.